Prevalence of thyroid diseases and antithyroid antibodies in women with rheumatoid arthritis

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 1-2, 2009, Pages 39-44

  Przygodzka, Małgorzata ^a   Filipowicz Sosnowska, Anna ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

Autoimmune thyroid disease (ATD); Rheumatoid arthritis (RA); Thyroid antibodies

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; LEVOTHYROXINE; METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE; THIAMAZOLE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HYPOTHYROIDISM; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PREVALENCE; RHEUMATOID ARTHRITIS; SCREENING TEST; THYROID FUNCTION;

EID: 61349164151     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.600     Document Type: Article

References (31)

1. Roitt IM, Doniachi D, Campbell PN. Autoantibodies in Hashimoto's disease (lymphadenoid goitre). Lancet. 1956; 2: 820.
2. Silman AJ, Oilier WER, Bubel MA. Autoimmune thyroid disease and thyroid autoantibodies in rheumatoid arthritis patients and their families. Br J Rheum. 1989; 28:18-21.
3. Bianchi G, Marchesini G, Zoli M, et al. Thyroid involvement in chronic inflammatory rheumatological disorders. Clin Rheum. 1994; 13:479-484.
4. Punzi L, Michelotto M, Pianon M, et al. Clinical, laboratory and immunogenetic aspects of arthritis associated with chronic lymphocytic thyroiditis. Clin Exp Rheum. 1997; 15: 373-380.
5. Shiroky JB, Cohen M, Ballachey ML, Neville C. Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey. Ann Rheum Dis. 1993; 52: 454-456.
6. Deighton CM, Fay A, Walker DJ. Rheumatoid arthritis in thyroid disease positive and negative same-sexed sibships. Br J Rheum. 1992; 31:13-17.
7. Caron P, Lassoued S, Dromer C, et al. Prevalence of thyroid abnormalities in patients with rheumatoid arthritis. Thyroidology. 1992; 4: 99-102.
8. Andonopoulos AP, Siambi V, Makri M, et al. Thyroid function and immune profile in rheumatoid arthritis. A controlled study. Clin Rheum. 1996; 15: 599-603.
9. Magnus JH, Birketvedt T, Haga H-J. A prospective evaluation of antithyroid antibody prevalence in 100 patients with rheumatoid arthritis. Scan J Rheumatol. 1995; 24:180-182.
10. Scofield RH. Autoantibodies as predictors of disease. Lancet. 2004; 363:1544-1546.
11. Dolȩga B, Szechiński J. [Evaluation of thyroid gland function in patients with rheumatoid arthritis]. Reumatologia. 1996; 24: 616-618. Polish.
12. Wilson GR, Curry RW. Subclinical thyroid diseases. Am Fam Physician. 2005; 72:1517-1524.
13. Arnett FC, Edworthy SM, Bloch DA. The American Rheumatism Association criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324.
14. Nauman J. [Results of studies performed with the MZ-XVII program on a national scale; summary and conclusions], Endokrynol Pol. 1991; 42: 360-367. Polish.
15. Pearce EN, Farwell AP, Bravemnan LE. Thyroiditis. N Engl J Med. 2003; 348: 2646-2655.
16. Ponikwicka E. [Thyroid function in RA patients]. Endokrynol Pol. 1999; Suppl. 3:328. Polish.
17. Chan ATY, Al-Saffar, Bucknall RC. Thyroid disease in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology. 2001; 40:353-354.
18. Marasini B, Massarotti M. Rheumatoid arthritis and thyroid disease. Clin Exp Rheumatol. 2004; 22: 265.
19. Del Puente A, Savastano S, Lupoli G, et al. High prevalence of thyroid autoantibodies in newly diagnosed rheumatoid arthritis patients. Clin Exp Rheumatol. 2003; 21:137.
20. Niemczyk S, Panasiuk-Jarzyło E, Matuszkiewicz-Rowińska J, Niemczyk L. [Assessment of the usefulness of the presence of antithyroid peroxidase antibodies (TPOAb) in patients with end-stage renal failure treated with hemodialysis]. Pol Arch Med Wewn. 2004; 111:687. Polish.
21. Bjoro T. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord - Trondelag (HUNT). Eur J Endorin. 2000; 143: 639-647.
22. Strieder TG, Prummel MF, Tijssen JG, et al. Risk factors for and prevalence of thyroid disorders in a cross- sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol (Oxf). 2003; 59: 396-401.
23. Nielen MM, van Schaardenburg D, Reesink HW. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004; 50:380-386.
24. Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow up of the Whickham Survey. Clin Endocrinol. 1995; 43: 55-68.
25. Walker DJ, Griffiths M, Griffiths ID. Occurrence of autoimmune diseases and autoantibodies in multicase rheumatoid arthritis families. Ann of Rheum Dis. 1986; 45, 323-326.
26. Dessein PH, Joffe Bl, Stanwix AE. Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis. Thyroid. 2004; 14: 443-446.
27. Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med. 2002; 137: 904-914.
28. Hueston WJ, Pearson WS. Subclinical hypothyroidism and the risk of hypercholesterolemia. Ann Fam Med. 2004; 2:351-355.
29. Meier C, Staub J-J, Roth C-B, et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab. 2001; 86: 4860-4866.
30. Cooper DS. Subclinical hypothyroidism. N Engl J Med. 2001; 345; 260-265.
31. Heffand M. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2004; 140:128-141.